News
Sanofi announced it is punting more than $9 billion to acquire Blueprint Medicines and its Ayvakit, BLU-808 and immunology ...
MarioGuti Most major stock indexes across the globe ended the week higher, as renewed optimism around US-China trade talks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results